
---
title: '抑制SAM生物合成减缓肿瘤生长'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202104/09/214009jzw166j33shbmwv0.png'
author: 科学网
comments: false
date: Fri, 09 Apr 2021 21:43:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202104/09/214009jzw166j33shbmwv0.png'
---

<div>   
<p style="line-height: 2em;"><span style="font-size: 24px; font-family: 黑体, SimHei;"><span style="font-size: 24px;">抑制</span><span style="font-size: 24px; font-family: "arial black", "avant garde";">SAM</span><span style="font-size: 24px;">生物合成减缓肿瘤生长</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">诸平</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">据威尔·多斯（</span><a href="https://news.feinberg.northwestern.edu/byline/will-doss/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Will Doss</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）</span> 2021<span style="font-size: 18px; font-family: 宋体;">年</span>4<span style="font-size: 18px; font-family: 宋体;">月</span>7<span style="font-size: 18px; font-family: 宋体;">日在美国</span></span><a href="https://news.feinberg.northwestern.edu/2021/04/inhibiting-sam-biosynthesis-to-slow-tumor-growth/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">西北大学网站</span></a><span style="font-size: 18px; font-family: "times new roman";">（</span><a href="https://news.feinberg.northwestern.edu/2021/04/inhibiting-sam-biosynthesis-to-slow-tumor-growth/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">https://news.feinberg.northwestern.edu/</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）提供的消息，该校研究人员研究发现，抑制</span>SAM<span style="font-size: 18px; font-family: 宋体;">生物合成可以减缓肿瘤生长。相关研究结果于</span>2021<span style="font-size: 18px; font-family: 宋体;">年</span>3<span style="font-size: 18px; font-family: 宋体;">月</span>22<span style="font-size: 18px; font-family: 宋体;">日已经在《分子细胞》（</span></span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Molecular Cell</span></a><span style="font-size: 18px; font-family: "times new roman";">）杂志网站发表——</span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Elodie Villa" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Elodie Villa</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Umakant Sahu" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Umakant Sahu</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Brendan P. O’Hara" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Brendan P. O’Hara</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Eunus S. Ali" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Eunus S. Ali</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Kathryn A. Helmin" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Kathryn A. Helmin</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author John M. Asara" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">John M. Asara</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Peng Gao" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Peng Gao</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Benjamin D. Singer" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Benjamin D. Singer</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" title="Correspondence information about the author Issam Ben-Sahra" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Issam Ben-Sahra</span></a><span style="font-size: 18px; font-family: "times new roman";">. </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">mTORC1 stimulates cell growth through SAM synthesis and m<sup>6</sup>A mRNA-dependent control of protein synthesis</span></a><span style="font-size: 18px; font-family: "times new roman";">. </span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Molecular Cell</span></a><span style="font-size: 18px; font-family: "times new roman";">, Published: March 22, 2021. DOI: </span><span style="text-decoration: underline; font-size: 18px; font-family: "times new roman";"><a href="https://doi.org/10.1016/j.molcel.2021.03.009" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank">https://doi.org/10.1016/j.molcel.2021.03.009</a>. </span></p><p style="line-height: 2em;"><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" style="font-size: 18px; font-family: "times new roman";" target="_blank">https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5</a></p><p><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202104/09/214009jzw166j33shbmwv0.png" title alt="1Issam-Ben-Sahra-300x276.png" referrerpolicy="no-referrer"><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">Fig. 1 </span><a href="https://news.feinberg.northwestern.edu/2021/04/inhibiting-sam-biosynthesis-to-slow-tumor-growth/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Issam Ben-Sahra, PhD, assistant professor of Biochemistry and Molecular Genetics, was senior author of the study published in Molecular Cell</span></a><span style="font-size: 18px; font-family: "times new roman";">.</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">美国西北大学发表在《分子细胞》杂志上的该项研究表明，许多癌症会劫持一种名为</span>mTOR<span style="font-size: 18px; font-family: 宋体;">的代谢机制来促进生长和增殖，而抑制该途径可能会减缓肿瘤的生长。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">伊萨姆·本</span>-<span style="font-size: 18px; font-family: 宋体;"><span style="font-family: 宋体; font-size: 18px;">萨</span>拉（</span>Issam Ben-Sahra<span style="font-size: 18px; font-family: 宋体;">）博士</span>(<span style="font-size: 18px; font-family: 宋体;">图</span>1)<span style="font-size: 18px; font-family: 宋体;">是西北大学范伯格医学院生物化学与分子遗传学系生物化学和分子遗传学的助理教授，也是该研究的通讯作者。他说，抑制蛋白质合成途径产生的关键材料的生产，可能是减缓肿瘤生长的有效策略。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">西北大学</span>Robert H. Lurie<span style="font-size: 18px; font-family: 宋体;">综合癌症中心（</span></span><a href="https://www.cancer.northwestern.edu/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Robert H. Lurie Comprehensive Cancer Center</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）的成员伊萨姆·本</span>-<span style="font-size: 18px; font-family: 宋体;">沙拉说：“在癌细胞中，</span>mTOR<span style="font-size: 18px; font-family: 宋体;">总是处于激活状态，刺激肿瘤细胞生长和增殖的生物合成。我们认为，这种抑制剂可以与其他疗法联合使用，更有效地抑制肿瘤生长。”</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">mTOR<span style="font-size: 18px; font-family: 宋体;">通路调节细胞生长与养分利用率，帮助控制整个身体的新陈代谢。该途径起着传感器的作用</span>:<span style="font-size: 18px; font-family: 宋体;">如果有足够的营养物质，该途径就会激活并促进蛋白质的生物合成。图</span>2<span style="font-size: 18px; font-family: 宋体;">是在人类癌症模型中，</span>SAM<span style="font-size: 18px; font-family: 宋体;">抑制剂显著降低了癌症的生长的照片。其中涉及皮肤癌细胞（</span>skin cancer cells<span style="font-size: 18px; font-family: 宋体;">）、前列腺癌细胞（</span>prostate cancer cells<span style="font-size: 18px; font-family: 宋体;">）、肺癌细胞（</span> lung cancer cell<span style="font-size: 18px; font-family: 宋体;">）以及乳腺癌细胞（</span>breast cancer cell<span style="font-size: 18px; font-family: 宋体;">）。</span></span><span style="font-family: "times new roman"; font-size: 18px;"> </span></p><p><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202104/09/214028j099vjou8s0voy7o.png" title alt="2inhibitor_Ben_Sahra-285x300.png" referrerpolicy="no-referrer"><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">Fig. 2 </span><a href="https://news.feinberg.northwestern.edu/2021/04/inhibiting-sam-biosynthesis-to-slow-tumor-growth/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">SAM inhibitor drastically reduced cancer growth in models of human cancer.</span></a></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">在大多数癌症中，</span>mTOR<span style="font-size: 18px; font-family: 宋体;">通路不断被激活，促进异常生长和增殖。该通路在称为淋巴管平滑肌瘤病</span>(lymphangioleiomyomatosis<span style="font-size: 18px; font-family: 宋体;">简称</span>LAM)<span style="font-size: 18px; font-family: 宋体;">和结节性硬化症</span>(tuberous sclerosis complex<span style="font-size: 18px; font-family: 宋体;">简称</span>TSC)<span style="font-size: 18px; font-family: 宋体;">的罕见遗传疾病中也被上调，在这些疾病中，非癌性肿瘤生长在身体的许多部位。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">然而，</span>mTOR<span style="font-size: 18px; font-family: 宋体;">激活在癌症和肿瘤综合症疾病中的具体作用，仍在很大程度上有待研究，</span><span style="font-size: 18px; font-family: 宋体;">本</span><span style="font-family: "times new roman"; font-size: 18px;">-</span><span style="font-size: 18px; font-family: 宋体;">萨拉</span><span style="font-size: 18px; font-family: 宋体;">说。在目前的研究中，范伯格医学院（</span>Feinberg School of Medicine<span style="font-size: 18px; font-family: 宋体;">）的科学家们使用癌症和癌细胞系的小鼠模型来研究癌症是如何利用</span>mTOR<span style="font-size: 18px; font-family: 宋体;">的。他们发现，不同类型的癌症，包括乳腺癌、前列腺癌和黑色素瘤（</span>melanoma<span style="font-size: 18px; font-family: 宋体;">），都有不同的</span>mTOR<span style="font-size: 18px; font-family: 宋体;">调控机制，但都显示出激活</span>mTOR<span style="font-size: 18px; font-family: 宋体;">的特定基因。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">本</span>-<span style="font-size: 18px; font-family: 宋体;">萨拉说：“这些癌症有不同的突变驱动它们，但它们都有一个共同点</span>: </span><span style="font-family: 宋体; font-size: 18px;">高的</span><span style="font-family: "times new roman"; font-size: 18px;">mTOR</span><span style="font-size: 18px; font-family: 宋体;">信号传送。”</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">然而，这种激活与正常细胞不同。虽然</span>mTOR<span style="font-size: 18px; font-family: 宋体;">对所有细胞生长都至关重要，但癌症驱动的</span>mTOR<span style="font-size: 18px; font-family: 宋体;">激活会特异性地产生大量的</span>S-<span style="font-size: 18px; font-family: 宋体;">腺苷甲硫胺酸</span>(S-adenosylmethionine<span style="font-size: 18px; font-family: 宋体;">简称</span>SAM)<span style="font-size: 18px; font-family: 宋体;">，这是蛋白质合成所需的一种代谢物。本</span>-<span style="font-size: 18px; font-family: 宋体;">萨拉说，这提供了一个机会。“我们不想让</span>mTOR<span style="font-size: 18px; font-family: 宋体;">在体内的任何地方都成为目标，这可能会有一些令人讨厌的副作用。但这种新的代谢途径对癌症的生长非常重要，因为它是高度活跃的。”</span></span></p><p><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202104/09/214039l8c5ceovtwtz3aat.jpg" title alt="3Elodie-Villa-232x300.jpg" referrerpolicy="no-referrer"><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">Fig. 3 </span><a href="https://news.feinberg.northwestern.edu/2021/04/inhibiting-sam-biosynthesis-to-slow-tumor-growth/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Elodie Villa, PhD, postdoctoral fellow in the Ben-Sahra laboratory, was lead author of the study published in Molecular Cell</span></a><span style="font-size: 18px; font-family: "times new roman";">.</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: 宋体;">为了研究这一现象，本</span><span style="font-family: "times new roman"; font-size: 18px;">-</span><span style="font-size: 18px; font-family: 宋体;">萨拉和他的合作者进行了异种移植（</span><span style="font-family: "times new roman"; font-size: 18px;">xenografts</span><span style="font-size: 18px; font-family: 宋体;">），将来源于患者的癌细胞移植到小鼠体内，并将</span><span style="font-family: "times new roman"; font-size: 18px;">SAM</span><span style="font-size: 18px; font-family: 宋体;">抑制剂应用到这些受试者身上。根据本</span><span style="font-family: "times new roman"; font-size: 18px;">-</span><span style="font-size: 18px; font-family: 宋体;">萨拉的解释，虽然这种抑制剂最初是作为生化研究的工具而设计的，但它有减缓癌症生长的效果，而且无严重后果。</span><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">本</span>-<span style="font-size: 18px; font-family: 宋体;">萨拉说</span>:<span style="font-size: 18px; font-family: 宋体;">“我们不知道会发生什么，但我们很高兴看到所有增殖的癌细胞都受到了影响，而受试老鼠没有表现出任何明显的副作用。”本</span>-<span style="font-size: 18px; font-family: 宋体;">萨拉希望这种工具可以在未来用于治疗，使其更有效，对癌细胞和</span>TSC<span style="font-size: 18px; font-family: 宋体;">细胞更有针对性。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">本</span>-<span style="font-size: 18px; font-family: 宋体;">萨拉说</span>:<span style="font-size: 18px; font-family: 宋体;">“我们认为我们可以将这个工具应用于癌症患者，作为辅助治疗。”</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">本</span>-<span style="font-size: 18px; font-family: 宋体;">萨拉实验室博士后研究员</span>E</span><span style="font-size: 18px; font-family: 宋体;">伊洛蒂·维拉（</span><span style="font-family: "times new roman"; font-size: 18px;">Elodie Villa</span><span style="font-size: 18px; font-family: 宋体;">）博士（图</span><span style="font-family: "times new roman"; font-size: 18px;">3</span><span style="font-size: 18px; font-family: 宋体;">）</span><span style="font-size: 18px; font-family: "times new roman";"><span style="font-family: 宋体;">是这项研究的主要作者，也是</span></span><span style="font-size: 18px; font-family: 宋体;">发表在《分子细胞》上的这项研究的第一作者，此研究</span><span style="font-size: 18px; font-family: "times new roman";"><span style="font-family: 宋体;">得到结节性硬化症联盟（</span></span><a href="https://www.tsalliance.org/" target="_blank" style="font-size: 18px; font-family: "times new roman";">Tuberous Sclerosis Alliance</a><span style="font-size: 18px; font-family: "times new roman";">）的支持。</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">此研究的合作者包括本杰明·辛格（</span>Benjamin Singer<span style="font-size: 18px; font-family: 宋体;">）医学助理教授和血液学和肿瘤学部研究助理教授、西北大学卢里癌症中心代谢组学核心设施（</span> </span><a href="https://www.cancer.northwestern.edu/research/shared-resources/metabolomics.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Lurie Cancer Center Metabolomics Core Facility</span></a><span style="font-size: 18px; font-family: "times new roman";">）部主任高鹏医学博士。动物工作是在西北发展治疗学核心（</span><a href="https://www.cancer.northwestern.edu/research/shared-resources/developmental-therapeutics.html" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Northwestern Developmental Therapeutics Core</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）部门的帮助下完成的。本杰明·辛格和高鹏是卢里癌症中心（</span>Lurie Cancer Center<span style="font-size: 18px; font-family: 宋体;">）的成员。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">这项工作得到了西北大学发展治疗学核心（</span>Developmental Therapeutics Core at Northwestern University<span style="font-size: 18px; font-family: 宋体;">）和</span>Robert H. Lurie<span style="font-size: 18px; font-family: 宋体;">综合癌症中心国家癌症研究所拨款（</span>CA060553<span style="font-size: 18px; font-family: 宋体;">）的支持</span>;<span style="font-size: 18px; font-family: 宋体;">以及西北蛋白质组学核心的支持</span>;<span style="font-size: 18px; font-family: 宋体;">也有来自美国国立卫生研究院（</span>National Institutes of Health<span style="font-size: 18px; font-family: 宋体;">）资助（</span>R00CA194192-04<span style="font-size: 18px; font-family: 宋体;">、</span>R01GM135587<span style="font-size: 18px; font-family: 宋体;">、</span>K08HL128867<span style="font-size: 18px; font-family: 宋体;">和</span>R01HL149883<span style="font-size: 18px; font-family: 宋体;">）</span>;LAM<span style="font-size: 18px; font-family: 宋体;">基金职业发展奖（</span> </span><a href="https://thelamfoundation.org/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">LAM Foundation</span></a><span style="font-size: 18px; font-family: "times new roman";"> Career Development Award LAM0127C01-18<span style="font-size: 18px; font-family: 宋体;">）</span>;<span style="font-size: 18px; font-family: 宋体;">结节性硬化症联盟（</span></span><a href="https://www.tsalliance.org/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Tuberous Sclerosis Alliance</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）博士后奖学金</span>(SP0057487)<span style="font-size: 18px; font-family: 宋体;">，菲利普基金会（</span>Philippe Foundation<span style="font-size: 18px; font-family: 宋体;">）和施维雅研究所（</span>Servier Institute<span style="font-size: 18px; font-family: 宋体;">）奖项的支持。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">上述介绍仅供参考，更多信息敬请注意浏览</span><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">原文</span></a><span style="font-size: 18px; font-family: "times new roman";">或者</span><a href="https://news.feinberg.northwestern.edu/2021/04/inhibiting-sam-biosynthesis-to-slow-tumor-growth/" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">相关报道</span></a><span style="font-size: 18px; font-family: "times new roman";">。</span></p><p style="line-height: 2em;"><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Highlights</span></a></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">• mTORC1 signaling stimulates S-adenosylmethionine synthesis</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">• The mTORC1-c-MYC axis controls MAT2A expression</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">• mTORC1 increases SAM levels and WTAP abundance to promote <em>N</em><sup>6</sup>-methylation of mRNA</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">• MAT2A activity is required to support protein synthesis and tumor growth</span></p><p style="line-height: 2em;"><a href="https://www.cell.com/molecular-cell/fulltext/S1097-2765(21)00177-5" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Summary</span></a></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">The mechanistic target of rapamycin complex 1 (mTORC1) regulates metabolism and cell growth in response to nutrient, growth, and oncogenic signals. We found that mTORC1 stimulates the synthesis of the major methyl donor, S-adenosylmethionine (SAM), through the control of methionine adenosyltransferase 2 alpha (MAT2A) expression. The transcription factor c-MYC, downstream of mTORC1, directly binds to intron 1 of MAT2A and promotes its expression. Furthermore, mTORC1 increases the protein abundance of Wilms’ tumor 1-associating protein (WTAP), the positive regulatory subunit of the human <em>N</em><sup>6</sup>-methyladenosine (m<sup>6</sup>A) RNA methyltransferase complex. Through the control of MAT2A and WTAP levels, mTORC1 signaling stimulates m<sup>6</sup>A RNA modification to promote protein synthesis and cell growth. A decline in intracellular SAM levels upon MAT2A inhibition decreases m<sup>6</sup>A RNA modification, protein synthesis rate, and tumor growth. Thus, mTORC1 adjusts m<sup><span style="font-family: "times new roman"; font-size: 7px;">6</span></sup>A RNA modification through the control of SAM and WTAP levels to prime the translation machinery for anabolic cell growth.</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自诸平科学网博客。<br>链接地址：</label><a href="http://blog.sciencenet.cn/blog-212210-1281191.html" target="_blank" style="font-size:13px; color:#850f0f">http://blog.sciencenet.cn/blog-212210-1281191.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-212210-1281096.html" target="_black">卷心菜中发现的一类新型蓝色物质可以代替合成食用染料</a><br>                    <!--大赛结束-->
                                        
  
</div>
            